ERIC THOMAS SCHMIDT Insider Trading $ALLO Allogene Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ERIC THOMAS SCHMIDT.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ERIC THOMAS SCHMIDT. ERIC THOMAS SCHMIDT is Director in RELMADA THERAPEUTICS, INC. ($RLMD) and Director in Revolution Medicines, Inc. ($RVMD) and Chief Financial Officer in Allogene Therapeutics, Inc. ($ALLO).
ERIC THOMAS SCHMIDT in Allogene Therapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of ERIC THOMAS SCHMIDT: Chief Financial Officer
Holdings: 96,097 shares
Latest Transaction: Mar 30 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of ERIC THOMAS SCHMIDT in Allogene Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALLO, RLMD, RVMD
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 30 2021 | ALLO | Allogene Therapeut ... | SCHMIDT ERIC THOMAS | Chief Financial Off ... | Option Exercise | A | 33.78 | 92,365 | 3,120,090 | 92,365 | |
| Mar 30 2021 | ALLO | Allogene Therapeut ... | SCHMIDT ERIC THOMAS | Chief Financial Off ... | Grant | A | 0.00 | 24,866 | 0 | 96,097 | 71.2 K to 96.1 K (+34.91 %) |
| Jan 19 2021 | ALLO | Allogene Therapeut ... | SCHMIDT ERIC THOMAS | Chief Financial Off ... | Sell | S | 33.29 | 400 | 13,314 | 1,152,595 | 1.2 M to 1.2 M (-0.03 %) |
| Jan 19 2021 | ALLO | Allogene Therapeut ... | SCHMIDT ERIC THOMAS | Chief Financial Off ... | Sell | S | 32.40 | 11,053 | 358,151 | 1,152,995 | 1.2 M to 1.2 M (-0.95 %) |
| Jan 19 2021 | ALLO | Allogene Therapeut ... | SCHMIDT ERIC THOMAS | Chief Financial Off ... | Sell | S | 31.69 | 3,547 | 112,393 | 1,164,048 | 1.2 M to 1.2 M (-0.30 %) |
| Jan 19 2021 | ALLO | Allogene Therapeut ... | SCHMIDT ERIC THOMAS | Chief Financial Off ... | Sell | S | 31.10 | 5,149 | 160,129 | 1,167,595 | 1.2 M to 1.2 M (-0.44 %) |
| Jan 19 2021 | ALLO | Allogene Therapeut ... | SCHMIDT ERIC THOMAS | Chief Financial Off ... | Sell | S | 30.60 | 9,851 | 301,481 | 1,172,744 | 1.2 M to 1.2 M (-0.83 %) |
| Oct 16 2020 | ALLO | Allogene Therapeut ... | SCHMIDT ERIC THOMAS | Chief Financial Off ... | Sell | S | 43.01 | 100 | 4,301 | 1,197,595 | 1.2 M to 1.2 M (-0.01 %) |
| Oct 16 2020 | ALLO | Allogene Therapeut ... | SCHMIDT ERIC THOMAS | Chief Financial Off ... | Sell | S | 42.32 | 2,099 | 88,840 | 1,197,695 | 1.2 M to 1.2 M (-0.17 %) |
| Oct 16 2020 | ALLO | Allogene Therapeut ... | SCHMIDT ERIC THOMAS | Chief Financial Off ... | Sell | S | 41.33 | 3,479 | 143,800 | 1,199,794 | 1.2 M to 1.2 M (-0.29 %) |
| Oct 16 2020 | ALLO | Allogene Therapeut ... | SCHMIDT ERIC THOMAS | Chief Financial Off ... | Sell | S | 40.07 | 4,218 | 169,011 | 1,203,273 | 1.2 M to 1.2 M (-0.35 %) |
| Oct 16 2020 | ALLO | Allogene Therapeut ... | SCHMIDT ERIC THOMAS | Chief Financial Off ... | Sell | S | 39.47 | 5,104 | 201,442 | 1,207,491 | 1.2 M to 1.2 M (-0.42 %) |
| Sep 22 2020 | ALLO | Allogene Therapeut ... | SCHMIDT ERIC THOMAS | Chief Financial Off ... | Sell | S | 37.04 | 1,911 | 70,783 | 1,212,595 | 1.2 M to 1.2 M (-0.16 %) |
| Sep 22 2020 | ALLO | Allogene Therapeut ... | SCHMIDT ERIC THOMAS | Chief Financial Off ... | Sell | S | 35.96 | 3,200 | 115,069 | 1,214,506 | 1.2 M to 1.2 M (-0.26 %) |
| Sep 22 2020 | ALLO | Allogene Therapeut ... | SCHMIDT ERIC THOMAS | Chief Financial Off ... | Sell | S | 34.76 | 9,889 | 343,692 | 1,217,706 | 1.2 M to 1.2 M (-0.81 %) |
| Sep 22 2020 | ALLO | Allogene Therapeut ... | SCHMIDT ERIC THOMAS | Chief Financial Off ... | Sell | S | 37.04 | 1,911 | 70,783 | 1,212,595 | 1.2 M to 1.2 M (-0.16 %) |
| Sep 22 2020 | ALLO | Allogene Therapeut ... | SCHMIDT ERIC THOMAS | Chief Financial Off ... | Sell | S | 35.96 | 3,200 | 115,069 | 1,214,506 | 1.2 M to 1.2 M (-0.26 %) |
| Sep 22 2020 | ALLO | Allogene Therapeut ... | SCHMIDT ERIC THOMAS | Chief Financial Off ... | Sell | S | 34.76 | 9,889 | 343,692 | 1,217,706 | 1.2 M to 1.2 M (-0.81 %) |
| Mar 20 2020 | ALLO | Allogene Therapeut ... | SCHMIDT ERIC THOMAS | Chief Financial Off ... | Option Exercise | A | 18.22 | 109,600 | 1,996,912 | 109,600 | |
| Mar 20 2020 | ALLO | Allogene Therapeut ... | SCHMIDT ERIC THOMAS | Chief Financial Off ... | Grant | A | 0.00 | 30,800 | 0 | 78,706 | 47.9 K to 78.7 K (+64.29 %) |
| Mar 18 2020 | ALLO | Allogene Therapeut ... | SCHMIDT ERIC THOMAS | Chief Financial Off ... | Sell | S | 20.25 | 300 | 6,075 | 47,906 | 48.2 K to 47.9 K (-0.62 %) |
| Mar 18 2020 | ALLO | Allogene Therapeut ... | SCHMIDT ERIC THOMAS | Chief Financial Off ... | Sell | S | 19.70 | 5,150 | 101,433 | 47,257 | 52.4 K to 47.3 K (-9.83 %) |
| Feb 24 2020 | ALLO | Allogene Therapeut ... | SCHMIDT ERIC THOMAS | Chief Financial Off ... | Sell | J | 25.30 | 237,155 | 6,000,022 | 1,227,595 | 1.5 M to 1.2 M (-16.19 %) |
| Mar 15 2019 | ALLO | Allogene Therapeut ... | SCHMIDT ERIC THOMAS | Chief Financial Off ... | Option Exercise | A | 26.89 | 83,500 | 2,245,315 | 83,500 | |
| Mar 15 2019 | ALLO | Allogene Therapeut ... | SCHMIDT ERIC THOMAS | Chief Financial Off ... | Grant | A | 0.00 | 49,400 | 0 | 49,400 | 0 to 49.4 K |
Page: 1